Today's Daily Dose brings you news about the reverse split of Applied DNA; the global strategic oncology collaboration between BeiGene and Amgen; better-than-expected earnings reported by Bio-Rad; upcoming catalysts of bluebird bio; licensing agreement between Dicerna Pharma and Roche; and an update on Recro Pharma's intravenous (IV) Meloxicam.
from RTT - Biotech https://ift.tt/2N4IJ8J
via IFTTT
No comments:
Post a Comment